
Ibopamine is currently used in Ophthalmology. Its action is on both adrenergic and dopaminergic receptors. The adrenergic receptors cause a marked mydriasis without accommodative paralysis, while the dopaminergic receptors increase the production of aqueous humor. Ibopamine may be useful for diagnostic purposes in Ophthalmology. This review article focuses on presenting the most intriguing evidence on ibopamine.